Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 5/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 4/20 | 0.59 |
| ▸ | MAPT | P10636 | 4/20 | 0.53 |
| ▸ | POLB | P06746 | 2/20 | 0.53 |
| ▸ | PKM | P14618 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | ESR1 | P03372 | 1/20 | 0.53 |
| ▸ | PGR | P06401 | 1/20 | 0.53 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.53 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.53 |
| ▸ | AR | P10275 | 1/20 | 0.53 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.53 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.53 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5687086 | 0.94 | HSD17B10 (0.70) | ELANEHSD17B10LMNAMAPTPOLB | |
| SCHEMBL9339013 | 0.84 | ELANE (0.83) | ELANEHSD17B10LMNAMAPTPOLB | |
| SCHEMBL8840297 | 0.83 | ELANE (0.46) | ELANEHSD17B10LMNAMAPTKMT2A | |
| SCHEMBL269329 | 0.83 | LMNA (0.80) | ELANEHSD17B10LMNAMAPTPOLB | |
| SCHEMBL909307 | 0.83 | CA12 (0.51) | ELANEHSD17B10LMNAMAPTPOLB | |
| SCHEMBL3292329 | 0.82 | ALDH1A1 (0.43) | ELANEHSD17B10MAPTKMT2AESR1 | |
| SCHEMBL5831547 | 0.82 | ELANE (0.67) | ELANEHSD17B10LMNAMAPTPOLB | |
| SCHEMBL5831549 | 0.82 | ELANE (0.67) | ELANEHSD17B10LMNAMAPTPOLB | |
| SCHEMBL9762610 | 0.82 | ELANE (0.67) | ELANEHSD17B10LMNAMAPTPOLB | |
| SCHEMBL11594845 | 0.82 | ELANE (0.47) | ELANEHSD17B10MAPTKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 518 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117085143-A | PROTACs nano blocking agent for estrogen receptor and preparation method and application thereof | 郑州大学 | 2023-11-21 | — | — | CN | claimed |
| CN-115975343-A | Liquid crystal epoxy resin composite material with ultralow dielectric loss and preparation method thereof | 西京学院 | 2023-04-18 | — | — | CN | claimed |
| US-10927101-B2 | Neopetrosides A and B, and synthesis method thereof | INJE UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) | 2021-02-23 | — | — | US | claimed |
| CN-107266318-B | Polysiloxane compound, method for preparing the same, and copolycarbonate resin comprising the same | LG化学株式会社 | 2020-07-03 | — | — | CN | claimed |
| US-20190218206-A1 | NEOPETROSIDES A AND B, AND SYNTHESIS METHOD THEREOF | INJE UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) | 2019-07-18 | — | — | US | claimed |
| US-9452969-B2 | Polyorganosiloxane compound, method for preparing the same, and copolycarbonate resin comprising the same | LG CHEM, LTD. (KR) | 2016-09-27 | — | — | US | claimed |
| US-20160145187-A1 | POLYORGANOSILOXANE COMPOUND, METHOD FOR PREPARING THE SAME, AND COPOLYCARBONATE RESIN COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2016-05-26 | — | — | US | claimed |
| JP-58013560-A | — | — | None | — | — | JP | disclosed |
| JP-57021352-A | — | — | None | — | — | JP | disclosed |
| JP-60199859-A | — | — | None | — | — | JP | disclosed |
| JP-60156646-A | — | — | None | — | — | JP | disclosed |
| JP-2006412-A | — | — | None | — | — | JP | disclosed |
| JP-55038309-A | — | — | None | — | — | JP | disclosed |
| US-4102979-A | IODINE LABEL, COCAINE | HOFFMANN-LA ROCHE INC. (US) | 1978-07-25 | — | — | US | disclosed |
| US-4064254-A | ANTIARRHYTHMIC AND ANTISEROTONINE AGENTS | MEAD JOHNSON & COMPANY (US) | 1977-12-20 | — | — | US | disclosed |
| US-4041040-A | Ecgonine derivative | HOFFMANN-LA ROCHE INC. (US) | 1977-08-09 | — | — | US | disclosed |
| US-4009208-A | N,N'-HEPTAMETHYLENEBIS(4-METHOXYBENZAMIDE) | STERLING DRUG INC. (US) | 1977-02-22 | — | — | US | disclosed |
| US-4000143-A | ANTIARRHYTHMIC AND ANTISEROTONIN AGENTS | MEAD JOHNSON & COMPANY (US) | 1976-12-28 | — | — | US | disclosed |
| US-3940407-A | β-Adrenergic blocking agents in the 1,2,3-thiadiazole series | SYNTEX (U.S.A.) INC. (US) | 1976-02-24 | — | — | US | disclosed |
| US-3931195-A | ANTIARRHYTHMIA, ANTISEROTONIN | MEAD JOHNSON & COMPANY (US) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190218206-A1 | NEOPETROSIDES A AND B, AND SYNTHESIS METHOD THEREOF | NPPA, NME4, PINK1 | ELANE 2309/4885HSD17B10 3984/4885LMNA 1515/4885 |
| US-20160145187-A1 | POLYORGANOSILOXANE COMPOUND, METHOD FOR PREPARING THE SAME, AND COPOLYCARBONATE RESIN COMPRISING THE SAME | PUF60, RPL38, RIOX2 | ELANE 1694/4885HSD17B10 2120/4885LMNA 1101/4885 |
| US-10927101-B2 | Neopetrosides A and B, and synthesis method thereof | NPPA, NME4, PINK1 | ELANE 2309/4885HSD17B10 3984/4885LMNA 1515/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.